PLoS Med:阻力运动是否也可预防肥胖?

2021-06-28 MedSci原创 MedSci原创

阻力运动有助延缓衰老,改变体形、改进姿态,改善身体对碳水化合物的代谢机能,预防和帮助治疗糖尿病

肥胖是高收入国家日益严峻的公共健康问题。单进行阻力运动(Resistance exercise,RE)或结合有氧运动(Aerobic exercise,AE)是否可降低肥胖的风险尚未完全明确。

这是一项前瞻性的队列研究,旨在评估不同类型和频率的RE独立于AE之外与肥胖发生的相关性。

受试者是11938名18-89岁的、基线BMI<30 kg/m2的健康成年人,他们在1987-2005年期间完成了至少2次临床检查。采用标准化问卷收集自我报告的RE参与情况(每周多少天和多少分钟)。肥胖定义为随访时BMI≥30 kg/m2;此外,在基线腰围(WC,n=9490)或体脂百分比(PBF,n=8733)低于肥胖阈值的人群中,肥胖还定义为男性/女性腰围 (WC)>102/88 cm和体脂百分比(PBF)≥25%/30%。

平均随访6年,根据BMI、WC或PBF标准,分别有874名(7%)、726名(8%)和1683名(19%)受试者达到肥胖。根据年龄、性别、检查年份、吸烟状况、饮酒量、高血压、高胆固醇血症、糖尿病和AE等混杂因素校正后,与未进行RE的受试者相比,每周进行60-119分钟的RE与根据BMI、WC和PBF定义的肥胖风险分别降低30%、41%和31%相关(风险比分别是0.70[p=0.008]、0.59[p<0.001]和0.69[p<0.001])。

运动量达到指南推荐量与否的肥胖风险

RE指南推荐每周运动至少2天。与每周运动不足2天相比,每周运动2天或以上与根据BMI、WC和PBF定义的肥胖风险分别降低18%、30%和30%相关(风险比分别是0.82[p=0.02]、0.70[p<0.001]和0.70[p<0.001])。

与运动量低于AE和RE指南推荐量的个体相比,运动量达到两种指南推荐量的个体发展成肥胖的风险比最低。此外,该研究的局限有纳入的人群的代表性有限(主要是中上层社会经济阶层的白人男性)、使用自我报告的RE以及大多数受试者缺乏详细的饮食数据。

总而言之,该研究提示阻力运动与肥胖风险降低显著相关

注释:阻力运动是一种对抗阻力的运动,主要目的是训练人体的肌肉,具体项目有杠铃弯举、仰卧起坐、深蹲起、哑铃单臂弯举。阻力运动有助延缓衰老,改变体形、改进姿态,改善身体对碳水化合物的代谢机能,预防和帮助治疗糖尿病。

原始出处:

Brellenthin Angelique G,Lee Duck-Chul,Bennie Jason A et al. Resistance exercise, alone and in combination with aerobic exercise, and obesity in Dallas, Texas, US: A prospective cohort study.[J] .PLoS Med, 2021, 18: e1003687. https://doi.org/10.1371/journal.pmed.1003687

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1054097, encodeId=59d4105409eb8, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Thu Sep 23 10:48:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611117, encodeId=4609161111eb3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jun 30 05:54:53 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977614, encodeId=c4559e761435, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de385535962, createdName=yayale0620, createdTime=Mon Jun 28 16:10:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977589, encodeId=a1ea9e75894e, content=阻力, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6785205858, createdName=1474c43fm46暂无昵称, createdTime=Mon Jun 28 15:23:36 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-09-23 我思故我在2

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1054097, encodeId=59d4105409eb8, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Thu Sep 23 10:48:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611117, encodeId=4609161111eb3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jun 30 05:54:53 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977614, encodeId=c4559e761435, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de385535962, createdName=yayale0620, createdTime=Mon Jun 28 16:10:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977589, encodeId=a1ea9e75894e, content=阻力, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6785205858, createdName=1474c43fm46暂无昵称, createdTime=Mon Jun 28 15:23:36 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1054097, encodeId=59d4105409eb8, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Thu Sep 23 10:48:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611117, encodeId=4609161111eb3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jun 30 05:54:53 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977614, encodeId=c4559e761435, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de385535962, createdName=yayale0620, createdTime=Mon Jun 28 16:10:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977589, encodeId=a1ea9e75894e, content=阻力, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6785205858, createdName=1474c43fm46暂无昵称, createdTime=Mon Jun 28 15:23:36 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-06-28 yayale0620

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1054097, encodeId=59d4105409eb8, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Thu Sep 23 10:48:51 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611117, encodeId=4609161111eb3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Jun 30 05:54:53 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977614, encodeId=c4559e761435, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de385535962, createdName=yayale0620, createdTime=Mon Jun 28 16:10:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977589, encodeId=a1ea9e75894e, content=阻力, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6785205858, createdName=1474c43fm46暂无昵称, createdTime=Mon Jun 28 15:23:36 CST 2021, time=2021-06-28, status=1, ipAttribution=)]
    2021-06-28 1474c43fm46暂无昵称

    阻力

    0

相关资讯

BMJ Open:肥胖与慢性鼻窦炎伴鼻息肉的关系

肥胖是一个迅速增长的全球健康问题。全球有超过19亿人归类为超重,超过6.5亿人归类为肥胖。与肥胖有关的疾病包括哮喘、心血管疾病和糖尿病。由于慢性炎症,某些类型的癌症也与肥胖症有关。有报告表明,肥胖有可

Brazilian Journal of Anesthesiology:肥胖患者术中机械通气的个体化与固定化呼气末正压的比较:一项二次分析

全身麻醉可能导致肥胖患者肺不张和氧合恶化。作者假设,与固定的呼气末正压(PEEP)相比,个体化呼气末正压可改善术中氧合和通气分布。

哈佛医学院:早晨吃巧克力可能有意想不到的益处?

女性在早上吃巧克力时,腰围缩小。

梅斯心血管疾病进展 (005期)

编者按:梅斯医学将定期进行汇总,帮助大家概览心血管领域最新进展。下面是呈现给大家的最新一期的心血管进展。enjoy~

Clinical Nutrition: 补充短双歧杆菌可改善肥胖儿童和青少年的胰岛素敏感性

肥胖是与代谢、心血管、呼吸系统疾病和癌症等多种疾病相关的重要公共卫生问题之一。在全球范围内,肥胖症的患病率迅速增加。

Anesthesiology:肥胖患者术中机械通气的个体化与固定化呼气末正压的比较:一项二次分析

身麻醉可能导致肥胖患者肺不张和氧合恶化。作者假设,与固定的呼气末正压(PEEP)相比,个体化呼气末正压可改善术中氧合和通气分布。